Ebola Emergency Hits Congo and Uganda With No Vaccine, Less US Aid

Around 80 suspected deaths and 246 suspected cases of a rare Ebola strain with no approved vaccine or antibody treatment pushed the World Health Organization on Sunday to declare a public health emergency of international concern across the Democratic Republic of the Congo and Uganda. The pathogen is Bundibugyo virus, last seen at scale during a 2007 Uganda outbreak, and the geography is Ituri Province, a gold-mining corridor that funnels people across three borders every week.

This is the first PHEIC declared since the Trump administration shut down the U.S. Agency for International Development and folded its remaining global health work into the State Department, and that timing is the real backbone of the story. The early-warning, lab-supply and contact-tracing scaffolding that propped up every Ebola response since 2014 is no longer where it was last year.

The Numbers Behind Sunday’s Declaration

The WHO outbreak news bulletin for the Bundibugyo cluster traces the index case to a health worker in Mongbwalu Health Zone whose symptoms began on April 24. He was transferred to Bunia, where he died. By May 14, the Institut National de Recherche Biomédicale in Kinshasa had confirmed Bundibugyo virus in eight of 13 blood samples drawn from neighbouring Rwampara Health Zone. DRC officials declared an outbreak the next day. Geneva announced the PHEIC two days after that.

• 246 suspected cases reported across three Ituri health zones (Bunia, Rwampara, Mongbwalu) as of May 16.
• 8 laboratory-confirmed cases in DRC and 2 in Uganda, including 1 confirmed death in Kampala.
• At least 4 healthcare workers dead at Mongbwalu General Referral Hospital, pointing to early breaches of infection prevention and control.
• Roughly 3 weeks between the presumed index symptom onset and laboratory confirmation, a delay public health teams describe as the dangerous window.

WHO Director-General Tedros Adhanom Ghebreyesus said the declaration does not meet pandemic criteria and advised governments against closing borders. He plans to convene the Emergency Committee under International Health Regulations as soon as members can be seated, with neighbouring South Sudan and Uganda flagged as high-risk for further spread.

A Strain Without a Shot

Bundibugyo is one of four Ebola virus species known to infect humans, and it sits outside the protective umbrella that Ervebo, the only licensed Ebola vaccine, has built over the past decade. Ervebo and the two licensed monoclonal antibody treatments, Inmazeb and Ebanga, all target the Zaire species. Bundibugyo gets none of that coverage.

Roger Kamba, the DRC’s Minister of Public Health, put the lethality range at up to 50 percent. Médecins Sans Frontières cites a tighter 25 to 40 percent fatality band based on prior outbreaks. The 2007 Uganda epidemic ran at about 32 to 40 percent depending on the diagnostic cut, according to the CDC’s published Bundibugyo case fatality analysis. Either way, the strain kills roughly one in every three people it infects, and the only clinical tools available are oxygen, fluids, blood-pressure support and the slim hope that the patient’s immune system gets there first.

Several candidate vaccines and a handful of pan-filovirus antibody therapies are in early-stage development, but none are licensed and none will be ready for deployment in this outbreak. The clinical-trial protocols that allowed experimental Zaire-strain countermeasures to be used during the 2018 to 2020 Kivu epidemic do not yet exist for Bundibugyo. Geneva’s bulletin calls for those protocols to be drafted now, in parallel with the outbreak response. That is a slow document for a fast virus.

The Aid Cuts Landed Before the Virus Did

Every Ebola outbreak in central Africa since 2014 has involved a thick American layer: USAID-funded epidemiologists, CDC field teams operating from country offices, a constellation of grantee organisations running cold-chain logistics, lab supply procurement, community engagement and safe-burial work. That layer has been peeled off in roughly fifteen months.

U.S. foreign aid spending fell 56.9 percent after the agency was wound down, according to figures cited by the International Panel for Pandemic Preparedness and Response. About $1.6 million of $2.2 million in active Ebola-specific prevention contracts was cancelled. The CDC’s overseas detail rosters have been thinned. Two billion dollars in pooled global health funding has been earmarked to cover wind-down costs at the former agency rather than program work.

With no USAID money and CDC expertise, it was like Uganda was left to die.

That was Dr. Herbert Luswata, president of the Uganda Medical Association, reflecting on the March 2025 Sudan-strain outbreak in Kampala, the first Ebola test of the post-USAID landscape. Jeremy Konyndyk, president of Refugees International and a former USAID Covid-19 response leader, told Common Dreams the question on the table now is whether the drawdown of American surveillance and detection support “undermined some of the surveillance and detection initiatives that might have helped to catch this earlier.” A three-week gap between symptom onset and lab confirmation is exactly the kind of detection failure that question is pointing at.

Africa CDC Steps Into the Gap

The institutional fallback is the African Union’s continental public health agency, Africa CDC, which convened an urgent high-level coordination call on May 15. The agency’s outbreak coordination readout lists the partners on the line.

• WHO and Africa CDC jointly running surveillance and laboratory confirmation across the affected zones.
• UNICEF and FAO on community engagement, water-sanitation-hygiene support and zoonotic risk tracing.
• Merck, Regeneron and Moderna consulted on whether any in-development Bundibugyo countermeasures can be moved into a trial protocol fast.
• Médecins Sans Frontières embedding clinical teams in Bunia and Mongbwalu treatment centres.
• World Bank and the Gates Foundation on the funding line, with cross-border surveillance, IPC and safe-burial protocols flagged as the immediate spending priorities.

The European, Chinese and remnant U.S. CDC desks are on the partner list too. Dr. Jean Kaseya, Africa CDC’s director general, said the agency “stands in solidarity” with the DRC government. The diplomatic phrasing covers a harder operational fact: continental institutions are now expected to carry weight that bilateral U.S. funding used to carry, and they are doing so with budgets that were already stretched before the foreign aid recalibration in Washington.

Bundibugyo’s Trail From 2007 to Now

This is the third recorded Bundibugyo outbreak. The earlier two left a usable template for what the next eight weeks may look like, and a warning about what gets missed when surveillance lags.

The 2007 Uganda episode burned for roughly four months before it was contained. Most onward transmission ran through unprotected funerals and through hospitals where infection control collapsed under caseload. The 2012 DRC cluster was smaller because Isiro is more isolated. Ituri is the opposite of isolated. Bunia hosts a regional airport. Mongbwalu sits on a gold-mining corridor that pulls in seasonal workers from across the Great Lakes region. Population movement is the variable that will decide whether case counts plateau in June or compound through July.

The Cross-Border Risk Is Already Live

Uganda’s two confirmed cases reached Kampala, not a border town. The man who died on May 14 was admitted after travelling from DRC; the second case had no obvious epidemiological link to him, which is the more troubling fact. Two unlinked imports inside a 24-hour window suggest the chain in DRC is wider than the 246 suspected-case figure shows.

Exit screening at international points of entry, contact tracing in Kampala, ring-style containment in Ituri and a regional emergency operations centre are all on the IHR recommendation list the WHO PHEIC determination issued on Sunday. South Sudan is the next-most-likely cross-border spillover, with Burundi, Rwanda and the Central African Republic flagged as elevated risk. None of those health systems has surge capacity that survives a sustained imported caseload.

If laboratory turnaround stays under 48 hours and contact tracing closes the loop on the Kampala imports, the precedent from 2007 says this outbreak can be contained in three to four months at a fatality count in the low hundreds. If the detection lag holds at three weeks and another capital city reports an unlinked import before the Emergency Committee seats, the response stops looking like 2007 and starts looking like the first six months of 2014.

Frequently Asked Questions

Is there a vaccine for the Bundibugyo strain of Ebola?

No licensed vaccine exists for Bundibugyo virus. The only approved Ebola vaccine, Ervebo, targets the Zaire species and is not expected to provide cross-protection. Several candidate vaccines are in preclinical or early clinical development but none can be deployed in this outbreak.

How deadly is Bundibugyo virus compared to other Ebola strains?

Bundibugyo runs at roughly a 25 to 40 percent case fatality rate based on prior outbreaks, lower than Zaire-strain Ebola (which can exceed 80 percent) but still among the most lethal viral diseases ever recorded. The DRC health ministry has used a wider range of up to 50 percent for this outbreak pending full clinical data.

Has the WHO advised travel restrictions on DRC or Uganda?

No. Director-General Tedros Adhanom Ghebreyesus specifically advised against closing borders. The IHR recommendations focus on exit screening at international points of entry, traveller risk communication and contact tracing rather than travel bans.

Why are US foreign aid cuts being linked to this outbreak?

Public health experts including Jeremy Konyndyk of Refugees International and Dr. Craig Spencer have publicly questioned whether the dismantling of USAID and reductions to CDC global health staffing weakened the early-detection systems that historically caught Ebola spillover earlier. A three-week gap between the index case’s symptoms and lab confirmation is being cited as evidence of that weakening.

What happens next under the PHEIC declaration?

The PHEIC triggers a coordinated international response under the International Health Regulations. WHO will convene an Emergency Committee, member states are obliged to share surveillance data, and partner agencies including Africa CDC, UNICEF and Médecins Sans Frontières scale up field operations. The committee typically reviews the declaration every three months.